Table 2.
Neuropathological diagnoses and corresponding demographic data. Abbreviations: ATP = Alzheimer‐type pathology; CBD = corticobasal degeneration; MSA = multiple system atrophy; PD = idiopathic Parkinson's disease; PEP = postencephalitic Parkinsonism; PSP = progressive supranuclear palsy; VaP = vascular Parkinsonism; W/M = women/men.
| Neuropathological diagnosis | Number of cases | % | Mean age at death ± SD (age range) | W/M | Mean duration of the diseasea |
|---|---|---|---|---|---|
| PD | 163 | 62.2 | 79.6 ± 7.4 (56–96) | 79/84 | 7.6 ± 6.1 (44) |
| PSP | 11 | 4.2 | 79.8 ± 8.5 (60–88) | 3/8 | |
| MSA | 6 | 2.3 | 65.0 ± 4.8 (58–73) | 3/3 | |
| CBD | 3 | 1.2 | 74.3 ± 6.5 (68–81) | 0/3 | |
| PEP | 7 | 2.7 | 49.4 ± 14.7 (32–70) | 5/2 | 17.8 ± 9.2 (5) |
| VaP | 23 | 8.8 | 81.3 ± 7.6 (67–98) | 9/14 | 4.6 ± 5.0 (8) |
| ATP | 21 | 8.0 | 84.9 ± 5.3 (73–93) | 11/10 | 6.1 ± 2.0 (8) |
| No specific lesion | 25 | 9.5 | 82.4 ± 6.0 (65–91) | 15/10 | |
| Moderate‐severe neuronal loss | 2 | 0.8 | 79 (79) | 1/1 | |
| Drug‐induced Parkinsonism | 11 | 4.2 | 81.8 (65–91) | 5/6 | |
| No etiology | 12 | 4.5 | 83.5 (75–90) | 9/3 | |
| Metastasis | 1 | 0.4 | 80 | 1/0 | |
| Cerebral abscess | 1 | 0.4 | 85 | 1/0 | |
| Total | 261 | 100 | 79.3 (32–98) | 125/136 |
a
In brackets, the number of cases with available data; further explications in the text.